Nuvalent Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Nuvalent Inc
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company’s operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
/ 
Frequently asked questions
To buy Nuvalent Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Nuvalent Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Nuvalent Inc is NUVL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Nuvalent Inc has its primary listing on NASDAQ. You can trade Nuvalent Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nuvalent Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Nuvalent Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Nuvalent Inc.